期刊文献+

Radiotherapy combined with surgical treatment for gastric cancer:a meta-analysis 被引量:1

放疗联合手术治疗胃癌的Meta-分析(英文)
下载PDF
导出
摘要 Objective:We carried out a meta-analysis to assess the effectiveness and safety of radiotherapy combined with surgery for gastric cancer.Methods:Randomized Clinical Trials (RCTs) in which radiotherapy (preoperative,intraoperative and postoperative),was compared with surgery alone in resectable gastric cancer were identified by searching Cochrane Library (Issue 2,2009),PubMed (Jan 1966-Jun 2009),EMBASE (Jan 1974-Jun 2009),Chinese Biomedical Literature Database (Jan 1978-Jun 2009),Chinese Science and Technology Periodicals Database (Jan 1989-Jun 2009),China National Knowledge Infrastructure (Jan 1994-Jun 2009) and Wanfang database (Jan 1997-Jun 2009) in English and Chinese languang.Two researchers assessed the quality of included randomized controlled trials (RCT) extracted data independently.The RevMan 5.0 software was used for meta-analysis.Our researchers assessed the quality of included randomized controlled trials (RCT) extracted data independently.The RevMan 5.0 software was used for meta-analysis.Results:Nine randomized controlled trials of 1 548 patients were selected for meta-analysis.Five randomized controlled trials were related with comparison of preoperative radiotherapy plus surgery with single surgery.Two randomized controlled trials were the comparative studies between surgery plus postoperative and single surgery.The meta-analysis results showed that:(1) compared with surgery alone,preoperative radiotherapy combined with surgery can increase 3 years (OR=1.78;95% CI 1.14-2.78,P=0.01),5 years (OR=1.67;95% CI 1.22-2.29,P=0.001),10 years (OR=1.64;95% CI 1.03-2.60,P=0.04) survival rate and resection rate (OR=2.15;95% CI 1.31-3.54,P=0.003);reduce the of tumor recurrence rate (OR=0.59;95% CI 0.37-0.92,P=0.02) and metastasis rate (OR=0.44;95% CI 0.27-0.73,P=0.001);(2) The tumor recurrent rates (OR=0.19,95% CI 0.03-1.14,P=0.07) and tumor metastasis rate (OR=0.09;95% CI 0.00-1.77,P=0.11) had no difference between single surgery group and peri-operative radiotherapy plus surgery group;(3) Postoperative radiotherapy compared with surgery alone had no significant effects on 1 year (OR=0.83;95% CI 0.60-1.15,P=0.26) and 3 years (OR=0.75;95% CI 0.51-1.11,P=0.15) survival rate compared with single surgery,but the 5-year survival rates (OR=0.57;95% CI 0.34-0.95,P=0.03) of the patients who received surgery alone was higher than those who received combined therapy.No difference of the tumor recurrence rate (OR=0.59;95% CI 0.33-1.05,P=0.07),tumor metestasis rate (OR=0.90;95% CI 0.51-1.59,P=0.71) and anastomotic leak (OR=0.98;95% CI 0.25-3.65,P=0.98) were observed between the two groups.Conclusion:Preoperative radiotherapy combined surgery is more rational and effective than surgery alone of gastric cancer.However,in terms of the clinical effects of perioperarive or postoperative radoiotherapy combined with surgery,much multicenter,largescale,high-quality,double-blind and rigorously designed studies would be needed than currently available in the future.
出处 《The Chinese-German Journal of Clinical Oncology》 CAS 2011年第8期442-449,共8页 中德临床肿瘤学杂志(英文版)
关键词 stomach neoplasms RADIOTHERAPY surgical procedure operative randomized controlled trial META-ANALYSIS 手术治疗 放疗 胃癌 随机对照试验 医学文献数据库 国家知识基础设施 Meta分析 手术切除
  • 相关文献

参考文献3

二级参考文献6

共引文献190

同被引文献11

  • 1Wei-guo Zhu,Da-fu Xua,Jun Pu,Cheng-dong Zong,Tao Li,Guang-zhou Tao,Fu-zhi Ji,Xi-lei Zhou,Ji-hua Han,Cheng-shi Wang,Chang-hua Yu,Jiang-guo Yi,Xi-long Su,Jin-xia Ding.A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection[J]. Radiotherapy and Oncology . 2012 (3)
  • 2Tae Hyun Kim,Sook Ryun Park,Keun Won Ryu,Young-Woo Kim,Jae-Moon Bae,Jun Ho Lee,Il Ju Choi,Yeon-Joo Kim,Dae Yong Kim.Phase 3 Trial of Postoperative Chemotherapy Alone Versus Chemoradiation Therapy in Stage III-IV Gastric Cancer Treated With R0 Gastrectomy and D2 Lymph Node Dissection[J]. International Journal of Radiation Oncology, Biology, Physics . 2012 (5)
  • 3Yung-Jue Bang,Young-Woo Kim,Han-Kwang Yang,Hyun Cheol Chung,Young-Kyu Park,Kyung Hee Lee,Keun-Wook Lee,Yong Ho Kim,Sang-Ik Noh,Jae Yong Cho,Young Jae Mok,Yeul Hong Kim,Jiafu Ji,Ta-Sen Yeh,Peter Button,Florin Sirzén,Sung Hoon Noh.Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial[J].The Lancet.2012(9813)
  • 4Stephen R. Smalley,Jacqueline K. Benedetti,Daniel G. Haller,Scott A. Hundahl,Norman C. Estes,Jaffer A. Ajani,Leonard L. Gunderson,Bryan Goldman,James A. Martenson,J. Milburn Jessup,Grant N. Stemmermann,Charles D. Blanke,John S. Macdonald.Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection[J].Journal of Clinical Oncology.2012(19)
  • 5Greg Knight,Craig C. Earle,Roxanne Cosby,Natalie Coburn,Youssef Youssef,Richard Malthaner,Rebecca K. S. Wong.Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America[J].Gastric Cancer.2013(1)
  • 6Rajini Seevaratnam,Alina Bocicariu,Roberta Cardoso,Alyson Mahar,Alex Kiss,Lucy Helyer,Calvin Law,Natalie Coburn.A meta-analysis of D1 versus D2 lymph node dissection[J].Gastric Cancer.2012(1)
  • 7Songun I,Putter H,Kranenbarg E,张信华.胃癌外科治疗:荷兰全国随机D1与D2临床试验15年随访结果报告[J].消化肿瘤杂志(电子版).2010(01)
  • 8Jung Ho Shim,Kyo Young Song,Hae Myung Jeon,Cho Hyun Park,Lindsay M. Jacks,Mithat Gonen,Manish A. Shah,Murray F. Brennan,Daniel G. Coit,Vivian E. Strong.Is Gastric Cancer Different in Korea and the United States? Impact of Tumor Location on Prognosis[J].Annals of Surgical Oncology.2014(7)
  • 9T. Waddell,M. Verheij,W. Allum,D. Cunningham,A. Cervantes,D. Arnold.Gastric cancer: ESMO–ESSO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up[J].European Journal of Surgical Oncology.2014(5)
  • 10Nitin Ohri,Madhur K. Garg,Santiago Aparo,Andreas Kaubisch,Wolfgang Tome,Timothy J. Kennedy,Shalom Kalnicki,Chandan Guha.Who Benefits From Adjuvant Radiation Therapy for Gastric Cancer? A Meta-Analysis[J].International Journal of Radiation Oncology Biology Physics.2013(2)

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部